Alkaline Phosphatase is the Only Liver Enzyme Physiologically Elevated in Normal Pregnancy
In normal pregnancy, alkaline phosphatase (ALP) is the only liver enzyme that naturally becomes elevated, specifically during the second and third trimesters due to placental production. All other standard liver enzymes—including ALT, AST, GGT, bilirubin, and bile acids—remain within normal ranges throughout pregnancy, and any elevation should prompt investigation for pathology 1.
Physiologically Normal Changes in Pregnancy
According to the 2021 AASLD guidelines on reproductive health and liver disease, the following biochemical patterns are expected in normal pregnancy 1:
Elevated Parameters:
- Alkaline phosphatase: Increases during the 2nd and 3rd trimesters (placental origin)
- Alpha-fetoprotein (AFP): Increases during 2nd and 3rd trimesters (fetal liver origin)
Decreased Parameters:
- Albumin: Normal to decreased throughout pregnancy due to hemodilution
Parameters That Remain Normal:
- ALT and AST: Remain within normal range throughout all trimesters
- Gamma-glutamyl transferase (GGT): Remains normal throughout pregnancy
- Bilirubin: Remains normal throughout all trimesters
- Bile acids: Remain within normal range
- Prothrombin time (PT): Remains normal
Critical Clinical Guidance
The AASLD provides explicit guidance: "Elevation in aminotransferases, bilirubin, or bile acids in pregnancy is abnormal and requires investigation" 1. This is a crucial clinical distinction—while many physiologic changes in pregnancy can mimic chronic liver disease (hyperdynamic circulation, spider angiomas, palmar erythema), actual liver enzyme elevations are never physiologic.
Common Clinical Pitfall
The most important pitfall is assuming that elevated transaminases (ALT/AST) are normal in pregnancy. They are not. While a 2005 study found that 7.4% of pregnant women had elevated ALT levels 2, and these were often transient and benign, this does not make them physiologically normal. Any elevation warrants evaluation for:
- Pregnancy-specific liver diseases (hyperemesis gravidarum, intrahepatic cholestasis of pregnancy, HELLP syndrome, acute fatty liver of pregnancy, preeclampsia)
- Pre-existing chronic liver disease
- Acute liver disease coincidental to pregnancy (viral hepatitis, drug-induced liver injury, biliary obstruction)
The 2023 EASL guidelines reinforce this approach, emphasizing that while ALP elevation is expected, transaminase or bile acid elevation requires systematic investigation 3.
Timing Considerations
The timing of ALP elevation is specific:
- 1st trimester: ALP remains normal
- 2nd trimester: ALP begins to increase
- 3rd trimester: ALP continues to be elevated
This placental-origin ALP typically resolves postpartum, and persistent elevation beyond 6 weeks postpartum warrants investigation for underlying liver disease 4.